Detalles de la búsqueda
1.
Oral insulin (ORMD-0801) in type 2 diabetes mellitus: A dose-finding 12-week randomized placebo-controlled study.
Diabetes Obes Metab
; 25(4): 943-952, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36281496
2.
A First-in-Human Study of AMG 986, a Novel Apelin Receptor Agonist, in Healthy Subjects and Heart Failure Patients.
Cardiovasc Drugs Ther
; 37(4): 743-755, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35460392
3.
Efficacy and safety of 28-day treatment with oral insulin (ORMD-0801) in patients with type 2 diabetes: A randomized, placebo-controlled trial.
Diabetes Obes Metab
; 23(11): 2529-2538, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34310011
4.
Human placental membrane as a wound cover for chronic diabetic foot ulcers: a prospective, postmarket, CLOSURE study.
J Wound Care
; 27(Sup7): S28-S37, 2018 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30008251
5.
Effect of evolocumab or ezetimibe added to moderate- or high-intensity statin therapy on LDL-C lowering in patients with hypercholesterolemia: the LAPLACE-2 randomized clinical trial.
JAMA
; 311(18): 1870-82, 2014 May 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-24825642
6.
Effect of Hepatic Impairment on the Pharmacokinetics of Nirmatrelvir/Ritonavir, the First Oral Protease Inhibitor for the Treatment of COVID-19.
J Clin Pharmacol
; 64(2): 145-154, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37751891
7.
A GIPR antagonist conjugated to GLP-1 analogues promotes weight loss with improved metabolic parameters in preclinical and phase 1 settings.
Nat Metab
; 6(2): 290-303, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38316982
8.
A Randomized, Placebo-Controlled Crossover Study to Evaluate Postprandial Glucometabolic Effects of Mulberry Leaf Extract, Vitamin D, Chromium, and Fiber in People with Type 2 Diabetes.
Diabetes Ther
; 14(4): 749-766, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-36855010
9.
Pharmacokinetics, Pharmacodynamics, and Tolerability of Olpasiran in Healthy Japanese and Non-Japanese Participants: Results from a Phase I, Single-dose, Open-label Study.
Clin Ther
; 44(9): 1237-1247, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35963802
10.
Pharmacokinetics of Oral Nirmatrelvir/Ritonavir, a Protease Inhibitor for Treatment of COVID-19, in Subjects With Renal Impairment.
Clin Pharmacol Ther
; 112(4): 892-900, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35712797
11.
Preclinical development and phase 1 trial of a novel siRNA targeting lipoprotein(a).
Nat Med
; 28(1): 96-103, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35027752
12.
An olmesartan medoxomil-based treatment algorithm is effective in achieving 24-hour BP control in patients with type 2 diabetes mellitus, regardless of age, race, sex, or severity of hypertension: subgroup analysis of the BENIFICIARY study.
Am J Cardiovasc Drugs
; 10(5): 289-303, 2010.
Artículo
en Inglés
| MEDLINE | ID: mdl-20712386
13.
Safety, Tolerability, and Physiological Effects of AXA1665, a Novel Composition of Amino Acids, in Subjects With Child-Pugh A and B Cirrhosis.
Clin Transl Gastroenterol
; 11(8): e00222, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32955200
14.
The use of a single-pill calcium channel blocker/statin combination in the management of hypertension and dyslipidemia: a randomized, placebo-controlled, multicenter study.
J Clin Hypertens (Greenwich)
; 11(1): 22-30, 2009 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-19125855
15.
Safety and tolerability of fixed-dose irbesartan/hydrochlorothiazide for rapid control of severe hypertension.
Clin Exp Hypertens
; 31(7): 572-84, 2009 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-19886855
16.
Irbesartan/hydrochlorothiazide for the treatment of isolated systolic hypertension: a subgroup analysis of the INCLUSIVE trial.
J Natl Med Assoc
; 101(4): 300-7, 2009 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-19397219
17.
Blood pressure control with amlodipine add-on therapy in patients with hypertension and diabetes: results of the Amlodipine Diabetic Hypertension Efficacy Response Evaluation Trial.
Ann Pharmacother
; 42(11): 1552-62, 2008 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-18827176
18.
Predictors of blood pressure response to angiotensin receptor blocker/diuretic combination therapy: a secondary analysis of the irbesartan/hydrochlorothiazide blood pressure reductions in diverse patient populations (INCLUSIVE) study.
J Clin Hypertens (Greenwich)
; 10(1): 27-33, 2008 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-18174768
19.
Hypertension control in the elderly.
J Clin Hypertens (Greenwich)
; 10(1 Suppl 1): 33-9, 2008 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-18174782
20.
Efficacy and safety of fixed combinations of irbesartan/hydrochlorothiazide in older vs younger patients with hypertension uncontrolled with monotherapy.
Am J Geriatr Cardiol
; 17(1): 27-36, 2008.
Artículo
en Inglés
| MEDLINE | ID: mdl-18174757